Nerbio Medical Software Platforms Inc.
Nerbio is a medical device company focused on patient monitoring, offering a "Medical Device as a Service" model. Their flagship product, the iTOF, is the world's first US FDA-cleared, app-controlled neuromuscular blockade (NMB) monitoring device. It utilizes advanced 3D accelerometry and Bluetooth connectivity, providing quantitative monitoring for anesthesia management. The iTOF system aims to improve safety and efficiency in operating rooms by reducing medication use, minimizing post-op events, and increasing OR throughput. The company emphasizes a low-cost subscription model, with costs as low as $1 per day, and includes a full replacement warranty with no disposable costs or capital expenditure. Nerbio is also developing an ecosystem of critical care monitoring solutions leveraging AI and advanced sensors, with a vision to transform patient monitoring into active clinical assistance through voice-enabled, hands-free interactions.
Nerbio Medical Software Platforms Inc.
Nerbio is a medical device company focused on patient monitoring, offering a "Medical Device as a Service" model. Their flagship product, the iTOF, is the world's first US FDA-cleared, app-controlled neuromuscular blockade (NMB) monitoring device. It utilizes advanced 3D accelerometry and Bluetooth connectivity, providing quantitative monitoring for anesthesia management. The iTOF system aims to improve safety and efficiency in operating rooms by reducing medication use, minimizing post-op events, and increasing OR throughput. The company emphasizes a low-cost subscription model, with costs as low as $1 per day, and includes a full replacement warranty with no disposable costs or capital expenditure. Nerbio is also developing an ecosystem of critical care monitoring solutions leveraging AI and advanced sensors, with a vision to transform patient monitoring into active clinical assistance through voice-enabled, hands-free interactions.
TL;DR
Headquarters: San Jose, California
Flagship product: iTOF — Bluetooth-enabled, app-controlled neuromuscular blockade (NMB) monitor
Business model: Medical Device as a Service (low-cost subscription)
Team size (reported): 18 employees
Funding rounds (recorded): Two Seed rounds (Mar 12, 2021; May 4, 2024)
Company Overview
Problem Domain
Perioperative and critical-care patient monitoring focused on neuromuscular blockade management and broader AI-enabled critical care monitoring.
Founded
2019
Industry
Medical devices / Healthcare software
Tech Stack
Funding Track Record
Most recent recorded round per Crunchbase